Y Oshodi1, O Ojewunmi2, T A Oshodi3, G T Ijarogbe4, O C Ogun4, O F Aina1, Fea Lesi5. 1. Department of Psychiatry, University of Lagos, Idiaraba, Lagos, Nigeria. 2. Department of Biochemistry, University of Lagos, Idiaraba, Lagos, Nigeria. 3. Department of Clinical Pathology, University of Lagos, Idiaraba, Lagos, Nigeria. 4. Department of Paediatrics, College of Medicine, University of Lagos, Idiaraba, Lagos, Nigeria. 5. The Child and Adolescent Center of the Federal Neuropsychiatric Hospital, Yaba, Lagos, Nigeria.
Abstract
BACKGROUND: The role of oxidative stress has been identified in the development of autism spectrum disorder (ASD), and polymorphisms of glutathione S-transferase have been associated with some diseases linked to oxidative stress. Hence, we evaluated the serum levels of oxidative stress markers and investigated genetic polymorphisms of glutathione S-transferase associated with autism. MATERIALS AND METHODS: Forty-two children clinically diagnosed with ASD using the Diagnostic and Statistical Manual for Mental Disorders (DSM-5) criteria and a clinical interview were included in the study. Twenty-three age-matched controls without any known genetic/developmental disorder were also recruited. Oxidative stress markers along with the genetic polymorphisms of glutathione S-transferase were determined. RESULTS: Reduced glutathione in ASD patients was significantly lower than the control (P = 0.008), whereas other oxidative stress markers measured were not significantly different in both the control and case populations. The frequencies of GSTT1 and GSTM1 null genotypes were lower among the controls compared with the cases, however, no association risk was observed. The observed risk of carrying Val/Val genotype among the cases was approximately six times that of the controls. CONCLUSION: Individuals with ASD showed a significant diminished level of reduced glutathione, however, the distribution of GSTT1, GSTM1, and GSTP1 polymorphisms was not found to be associated with autism in this study population.
BACKGROUND: The role of oxidative stress has been identified in the development of autism spectrum disorder (ASD), and polymorphisms of glutathione S-transferase have been associated with some diseases linked to oxidative stress. Hence, we evaluated the serum levels of oxidative stress markers and investigated genetic polymorphisms of glutathione S-transferase associated with autism. MATERIALS AND METHODS: Forty-two children clinically diagnosed with ASD using the Diagnostic and Statistical Manual for Mental Disorders (DSM-5) criteria and a clinical interview were included in the study. Twenty-three age-matched controls without any known genetic/developmental disorder were also recruited. Oxidative stress markers along with the genetic polymorphisms of glutathione S-transferase were determined. RESULTS: Reduced glutathione in ASDpatients was significantly lower than the control (P = 0.008), whereas other oxidative stress markers measured were not significantly different in both the control and case populations. The frequencies of GSTT1 and GSTM1 null genotypes were lower among the controls compared with the cases, however, no association risk was observed. The observed risk of carrying Val/Val genotype among the cases was approximately six times that of the controls. CONCLUSION: Individuals with ASD showed a significant diminished level of reduced glutathione, however, the distribution of GSTT1, GSTM1, and GSTP1 polymorphisms was not found to be associated with autism in this study population.
Authors: Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos Journal: Antioxid Redox Signal Date: 2019-02-01 Impact factor: 8.401
Authors: Antonietta Messina; Vincenzo Monda; Francesco Sessa; Anna Valenzano; Monica Salerno; Ilaria Bitetti; Francesco Precenzano; Rosa Marotta; Francesco Lavano; Serena M Lavano; Margherita Salerno; Agata Maltese; Michele Roccella; Lucia Parisi; Roberta I Ferrentino; Gabriele Tripi; Beatrice Gallai; Giuseppe Cibelli; Marcellino Monda; Giovanni Messina; Marco Carotenuto Journal: Front Physiol Date: 2018-03-22 Impact factor: 4.566